People living with HIV in California were highly satisfied with telephone visits during the height of the COVID-19 pandemic ...

The differences did not appear to be associated with potential moderating factors like age, sex, or smoking status.

In this second part of our interview with Kasey Bond, MPH, NYU Langone Health, we discuss the contributions of community ...

T-cell therapy yielded encouraging response rates and safety findings among patients with relapsed or refractory chronic ...

Patients with generalized myasthenia gravis experienced durable improvements across measures of efficacy and regardless of the time since they were diagnosed.

A phase 3 trial highlights betibeglogene autotemcel as a potentially curative gene therapy for severe transfusion-dependent β ...

A Mendelian analysis supports the idea that hyperuricemia may be an important risk factor for pulmonary arterial hypertension ...

The VET PFAS Act could help older veterans with toxic exposure attain the medical treatment they need by expanding ...

Tim Mok, PharmD, BCPS, BCOP, malignant hematology pharmacy research analyst at Kaiser Permanente, discussed his perspective on the balance between clinical outcomes and cost considerations.

Lockdowns instituted due to the COVID-19 pandemic could have brought about exacerbated immune responses in people living with ...

Tiago Biachi, MD, PhD, discusses the challenges of treating gastrointestinal (GI) cancers, particularly the limited effectiveness of immunotherapy for "cold tumors" and the need to make them more ...

In our ongoing conversation with James Cancer Hospital’s Don M. Benson, MD, PhD, he explains his philosophy of always ...